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Summary
Gene expression profiling identified human melanoma cells demonstrating increased cell motility and invasiveness. The
gene WNT5A best determined in vitro invasive behavior. Melanoma cells were transfected with vectors constitutively
overexpressing Wnt5a. Consistent changes included actin reorganization and increased cell adhesion. No increase in
-catenin expression or nuclear translocation was observed. There was, however, a dramatic increase in activated PKC.
In direct correlation with Wnt5a expression and PKC activation, there was an increase in melanoma cell invasion. Blocking
this pathway using antibodies to Frizzled-5, the receptor for Wnt5a, inhibited PKC activity and cellular invasion. Furthermore,
Wnt5a expression in human melanoma biopsies directly correlated to increasing tumor grade. These observations support
a role for Wnt5a in human melanoma progression.
Introduction overlapping patterns during gastrulation, and, in the adult, they
are expressed in a variety of tissues. Each of these signaling
proteins carries information distinct from other family members,The incidence of cutaneous melanoma is increasing, with an
estimate of 1 in 75 people in the United States contracting the and stimulation by multiple family members can produce results
different from either single input, implying that family membersdisease in the year 2000 (Landis et al., 1999). Although early
diagnosis is associated with a high cure rate, due to the highly can influence the interpretation of each others’ signals. Such
interactions provide the possibility of considerable subtlety andmalignant nature of this disease, 20% of diagnosed patients
will die from advanced disease. Unfortunately, it remains difficult complexity in Wnt signaling. Secreted Wnts associate with cell
surfaces and the extracellular matrix, and many are shown toto predict a priori which patients are more likely to develop highly
invasive disease, as melanoma types are essentially clinically closely associate with the Frizzled family of receptors (Yang-
Snyder et al., 1996). Wnt signaling has been shown to be impor-indistinguishable based upon routine histopathologic criteria
(Weyers et al., 1999). Therefore, markers of melanoma invasive- tant not only in development, but also in tumorigenesis. For
example, Wnt1 can signal via Frizzled to hyperphosphorylateness would be of both biological and possibly clinical utility. In
a recent study of the authors, gene expression analysis was and activate the disheveled gene, resulting in the inhibition of
GSK3- activity and the subsequent stabilization of its targetused to identify a series of genes whose expression differed
between cutaneous melanomas with differing invasive pheno- -catenin (Miller et al., 1999). -catenin can then accumulate
in the nucleus, altering chromatin structure, which results intypes (Bittner et al., 2000). One of the genes identified as a
particularly robust marker of highly aggressive behavior in this differential gene expression (Sharpe et al., 2001). As -catenin
is also known to interact with E-cadherin, a cell-cell adhesionstudy was the gene WNT5A.
Wnt5a is a member of the Wnt family of proteins, which are molecule, this further suggests a role for WNT genes in modulat-
ing cell-cell interactions (Moon et al., 1993).38–45-kDa secreted cysteine-rich proteins with hydrophobic
signal peptides. They have no transmembrane domains and are In tumorigenesis, the abnormal expression of the Wnt family
members can be divided into three distinct types of transformingposttranslationally modified by N-linked glycosylation (Moon et
al., 1997). Vertebrate WNT genes are expressed in unique but ability. The highly transforming members of this family include
S I G N I F I C A N C E
Comparative studies of metastatic versus nonmetastatic cells have identified several differences in morphology and behavior
between these phenotypes. It is more difficult to demonstrate how cells shift from one phenotype to the other. Many hypotheses
exist, from random accrual of the necessary changes during periods of chromosomal instability to dysregulation of normal cell-to-
cell signaling interactions. Here, we describe how increasing the level of a single signaling component can evoke a complex
change in cell phenotype reflecting the properties expected with a shift to a highly metastatic cancer cell phenotype. With the in
vitro observations directly correlating with results from human melanoma tumor biopsy samples, this paper provides support for the
notion that the Wnt5a pathway is of possible clinical significance in melanoma.
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Figure 1. The Wnt signaling pathways
Wnt1 signals via Frizzled to activate the disheveled protein, resulting in the stabilization of -catenin and its subsequent translocation. Wnt5a, however,
signals via Frizzled to activate PLC causing phospholipid turnover in the membrane, releasing calcium from intracellular stores and increasing PKC activity.
Wnt1, Wnt3a, and Wnt7a. The intermediately transforming cells and to examine the expression patterns of this protein in
members include Wnt2, Wnt5b, and Wnt7b, and the nontrans- human melanoma.
formers include Wnt4, Wnt5a, and Wnt7b (Jue et al., 1992; Wong
et al., 1994). In fact, Wnt5a can interact in a cell nonautonomous Results
manner to block Wnt1 signaling during development as well as
during transformation. For example, the expression of Wnt5a Overexpression of Wnt5a changes the morphology
can cause a failure of Wnt1 to duplicate the embryonic axis of melanoma cells
during Xenopus development (Torres et al., 1996). In tumorigen- UACC 1273 melanoma cells (derived from an axillary lymph
esis, mouse C57MG mammary cell transformation by an anti- node in a 54-year-old male patient) were selected based on
sense Wnt5a mimics Wnt1-mediated transformation (Olson and their low Wnt5a expression and low in vitro invasion (Bittner et
Gibo, 1998). Furthermore, ectopic expression of Wnt5a in uro- al., 2000). Cells were transfected with plasmid vectors capable
epithelial cancer reverts tumorigenesis (Olson et al., 1997). Thus, of constitutively expressing Wnt5a. Clones were selected in
while the signal transduction pathways of Wnt1 and Wnt5a
G418 and were examined for Wnt5a expression using both real-
remain very distinct from each other (Figure 1), Wnt5a appears
time PCR and immunohistochemistry (Figure 2). Clones that
to be able to affect the results of Wnt1 signaling.
expressed Wnt5a at significantly increased levels relative to the
It has been hypothesized that Wnt5a is an important regula-
parent are designated as 1273 1-3, 1273 4-3, and 1273 4-7.tor of cell growth and differentiation and that loss of expression
Clones designated 1273 1-1 and 1273 EV (empty vector) domay in some cases lead to transformation. However, there are
not express Wnt5a at levels significantly different than the paren-several other lines of evidence that indicate that continued or
tal line. Although there are no great differences in cell prolifera-increased Wnt5a expression is indeed important in cancer.
tion or apoptosis, the shape of cells expressing higher levelsWnt5a is upregulated in cancers of the lung, breast, and prostate
of Wnt5a is drastically different from the parental cell shape.and is downregulated in pancreatic cancer (Crnogorac-Jurcevic
The parental cells are compact, thick, and roughly triangular,et al., 2001; Iozzo et al., 1995; Lejeune et al., 1995). However, in
with few points of contact with the substrate and few extendedcancers of the bladder, there is no change in Wnt5a expression,
processes. The transfected daughter cells are thin and spread-implying that its loss is not a necessary precursor to tumorigene-
ing, with irregular shapes, many points of contact with the sub-sis in general (Bui et al., 1998). The overexpression of Wnt5a
strate, and numerous extended processes (Figure 3A). Whenin all of these tumors is not a result of gene amplification or
stained with fluorescent phalloidin in this study, actin clusteredrearrangement, suggesting that the level of Wnt5a is being mod-
in long filaments along the edges of the high-Wnt5a-expressingulated in these cases by some further regulatory apparatus. The
cells, but not in the low-Wnt5a-expressing cells (Figure 3B),present study aims to focus on the ability of Wnt5a to alter
phenotypes leading to increased invasiveness of melanoma suggesting that actin reorganization was a consequence of in-
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Figure 2. Wnt5a expression in transfected melanoma cells
UACC 1273 melanoma cells were transfected with Wnt5a under control of
the CMV promoter, using the Gateway cloning system from Invitrogen. Cells
were assayed for Wnt5a expression using both real-time PCR for the Wnt5a
transcript and immunohistochemistry for the Wnt5a protein.
Figure 3. Effects of Wnt5a transfection on melanoma cells
creasing Wnt5a in these cells. Actin also clustered at the edges
A: The morphological effects of Wnt5a transfection. The transfection ofof the cell processes, demonstrating what appeared to be mem-
Wnt5a into UACC 1273 cells results in a change from compact cobblestone-
brane ruffling, which is potentially indicative of increased cell shaped cells to irregularly shaped cells with many protruding processes. B:
The effects of Wnt5a transfection on actin rearrangement. Transfection ofmotility (arrows, Figure 3B). Wnt5a-transformed cells also
Wnt5a into UACC 1273 cells results in a polarization of actin at the edgesshowed more resistance to trypsinization than the parental or
of the cells. There is also evidence of actin ruffling, at the end of the elon-vector control cells, presumably indicating increased adhesion
gated cells (arrow), perhaps indicative of increased invasion. C: Wnt5a
to the extracellular matrix (ECM). In order to confirm this obser- increases cell adhesion. A total of 50,000 cells were seeded for the indicated
times, and nonadherent cells were rinsed off. Adherent cells were stainedvation, cell adhesion assays were performed. Cells transfected
with crystal violet and were analyzed spectrophotometrically. Cells trans-with Wnt5a (1273 4-3 and 1273 4-7) adhered more readily than
fected with Wnt5a adhered much sooner than cells transfected with anempty vector controls (Figure 3C).
empty vector control. D: Wnt5a does not affect -catenin expression and
translocation. Whether cells were transfected with an empty vector control
or Wnt5a, -catenin translocation to the nucleus could not be observed;Overexpression of Wnt5a in melanoma cells has no
staining remained pericellular. SW480 colon cancer cells, which have aeffect on -catenin expression or translocation
mutant APC gene resulting in overexpression of -catenin, were used as abut increases the activity of protein kinase C positive control and demonstrated abundant staining for nuclear -catenin.
-catenin mutations are thought to play some role in melanoma
(Rubinfeld et al., 1997), and -catenin is important in cell adhe-
sion. Based on the observation that Wnt5a-transfected cells
demonstrated changes in cell adhesion, we examined the effect (1273 1-3, 1273 4-3 and 1273 4-7, Figure 4A). In addition, spe-
of Wnt5a on -catenin in our transfectants. However, there cific isoforms of PKC were activated in the transfectants com-
was no change in -catenin expression, and expression was pared to the controls (Figure 4B). The two isoforms that were
localized to the periplasmic membrane and cell-cell junctions, most significantly increased in these transfectants were iso-
presumably in conjunction with E-cadherin (Figure 3D). forms  and /II, which are thought to be associated with
A signal transduction pathway known to be downstream of cytoskeletal organization and invasion, respectively (Bowden et
Wnt5a is the calcium pathway, which results in the activation al., 1999; Liu et al., 1994; Timar et al., 1996). The expression
of protein kinase C (PKC) (Kuhl et al., 2000). The PKC pathway of the various PKC isoforms in the Wnt5a transfectants and
has been shown to be important in melanoma and other can- their association with different aspects of cell growth and motility
cers, and its action is often associated with changes in the are summarized in Figure 4B.
cytoskeleton, cell adhesion, and motility (Szalay et al., 2001;
Timar et al., 1997), leading to the expectation that the pheno- Wnt5a leads to an increase in motility and invasion
typic changes observed upon increased Wnt5a expression Based on the observations that cell-ECM adhesion was in-
would result in observable increases in activation of PKC by creased and that isoforms of PKC known to be important in
phosphorylation. When the level of activated PKC was exam- cytoskeletal reorganization and motility were activated by Wnt5a
ined, it was dramatically increased only in the Wnt5a-transfected transfection, we examined the in vitro motility of these cells.
We observed a striking difference in the rates of motility of thecell lines that showed significantly increased Wnt5a expression
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Figure 4. Wnt5a and the PKC pathway
A: Wnt5a increases PKC activity. UACC 1273 and
clones transfected with Wnt5a were ordered on
a gel from low to high Wnt5a expression and
were then probed with an antibody to phospho-
PKC, to determine PKC activity. PKC activity was
strongly correlated to Wnt5a expression, as de-
termined by both Western analysis and real-time
PCR. B: PKC isoforms and cellular effects of their
activation. Wnt5a transfectants were analyzed
for their expression of the various PKC isoforms.
Shown here are two example Westerns for differ-
ences in activation of PKC / II and PKC (PKD)
upon Wnt5a transfection. The table beneath
summarizes the changes in activity for the various
PKC isoforms in each transfectant, and the
arrows indicate in which cellular functions the
various isoforms have been implicated. C: Wnt5a
transfection increases the invasive ability of mel-
anoma cells. Wnt5a stable transfectants were
assayed for invasion in a Boyden chamber assay
as described above. The clones were up to 6-fold
more invasive than the empty vector-trans-
fected cells. The cell lines shown here are or-
dered according to increasing PKC activation
and Wnt5a expression, and the results are the
sum total of four separate assays in which each
condition was performed in triplicate. p values
for all the assays were calculated using ANOVA
analysis. Interestingly, the clone 1273 1-1, which
did not significantly increase PKC activation, was
not statistically significant in its upregulation of
invasion (p  0.25) as compared to the other
clones (p values ranged between 0.02 and 0.08).
transfected cells expressing Wnt5a, correlating to increased crease in invasiveness (p value of 0.25). It is also of interest to
note that, after a certain level of PKC activity was attained, theremotility in endogenously high Wnt5a-expressing cells that were
identified by microarray analysis in the initial study by Bittner was no further effect on invasion, suggesting a threshold effect
for this mechanism. This idea of a threshold effect is supportedet al. (Bittner et al., 2000). In order to approximate in vitro inva-
siveness, we also performed Boyden chamber invasion assays, by the observation that, when Wnt5a was transfected into en-
dogenously high-Wnt5a-expressing melanoma cells, even inwhich mimic the three-step hypothesis of invasion-adhesion,
proteolytic dissolution of the extracellular matrix, and migration clones that did demonstrate increases in PKC activity, invasion
was already at a maximum level (Figure S1, see the Supplemen-(Albini, 1998). The cells are placed on a filter coated with recon-
stituted basement membrane, and migration (“invasion”) tary Material available with this article online at http://www.
cancercell.org/cgi/content/full/1/3/279/DC1).through the filter is analyzed by fluorimetry. Using this assay,
Wnt5a-transfected melanoma cells were up to four times more
invasive than empty vector controls or the original low-Wnt5a Disruption of the Wnt5a/Frizzled-5 pathway results
in an inhibition of PKC activation and reducedparental cells, with p values between 0.02 and 0.08 (Figure
4C). The invasion assay results correlate directly with the PKC invasiveness of melanoma cells
As increasing Wnt5a appeared to be positively correlated tophosphorylation assay results. Those clones showing increased
Wnt5a expression and PKC phosphorylation show significant motility and invasiveness, it was logical to determine whether
the inhibition of Wnt5a signaling would result in the inhibitionincreases in invasiveness (p values of 0.02–0.08), while clone
1-1, which shows neither increased Wnt5a expression nor in- of in vitro motility and invasion. Because Wnt5a binds to the
receptor Frizzled-5, and by this interaction can exert its signalingcreased PKC phosphorylation, does not show a significant in-
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Figure 5. Effects of inhibiting the Frizzled-5 receptor
A: Inhibition of the Fzd5 receptor results in a decrease in PKC activation. The Wnt5a transfectants were treated with a functional antibody to the receptor.
This resulted in a decrease in PKC activation in the antibody-treated cells, but not the IgG-treated cells. B: Inhibition of the Frizzled-5 receptor results in an
inhibition in invasion. Wnt5a transfectants, as well as one high endogenous expresser of Wnt, UACC 647, were pretreated with the antibody to the Frizzled
receptor or with IgG for 16 hr prior to the invasion assays. Fzd5-treated cells showed a drastic decrease in invasion as compared to IgG-treated or untreated
cells. No difference could be observed in the barely invading vector control cells. p values are shown for treated cells as compared to IgG controls. C:
Inhibition of the Frizzled-5 receptor results in an inhibition in invasion in a scratch assay. Wnt5a transfectants, as well as cell lines endogenously high in Wnt5a
(M93-047 is shown here as an example; for additional lines, see the Supplementary Material at http://www.cancercell.org/cgi/content/full/1/3/279/DC1)
were treated with antibody to the Fzd5 receptor in fibronectin-coated chambers. As with the Boyden chamber assays, Fzd5-treated cells showed a drastic
decrease in invasion as compared to IgG-treated or untreated cells. Note the still evident scratch in the Fzd5-treated cells even after 24 hr.
effects (Ishikawa et al., 2001; Sen et al., 2000), we first examined on a chamber slide, coated with either fibronectin or collagen,
grown to confluence, and then “scratched” with a sterile pipetteour cells for the presence of Frizzled-5. Using real-time RT-
PCR, we found that Frizzled-5 was indeed present in these cells, tip. The time that it takes for each cell line to invade the scratch
and begin to fill it can be used as a measure of motility (Bittnerand its expression remained unchanged by artificially increased
Wnt5a expression. An antibody against Frizzled-5 has been et al., 2000). These assays were performed both on the transfec-
tants and on cell lines endogenously high in Wnt5a expression,shown to disrupt the Wnt5a/Fzd5 interaction (Sen et al., 2001);
we obtained this antibody, purified the IgG, dialyzed the anti- as determined by microarray analysis. Transfectants 1273 4-3
and 1273 4-7 were significantly inhibited in their invasion evenbody, tested it by Western analysis, and treated cells with either
the antibody or purified dialyzed IgG from the preimmune serum as early as 12 hr (Figure 5C). Three cell lines endogenously high
in Wnt5a expression (UACC 930, UACC 647, and M93-047)at 100g/mL (antibody was replaced every 12 hr for the duration
of the assays). In contrast to controls, cells treated with antibody demonstrated similar rates of inhibition by the Frizzled-5 anti-
body, and the cell line M93-047 is shown here as an exampleto Frizzled-5 showed a marked decrease in the level of phospho-
PKC after 16–24 hr of treatment (Figure 5A). In addition, the in (Figure 5C). Other cell lines, UACC 647 and UACC 930, are
shown in Figure S2 contained in the Supplementary Materialvitro invasion or motility rates of these cells were significantly
decreased in the Boyden chamber invasion assay (Figure 5B), available with this article online (http://www.cancercell.org/cgi/
content/full/1/3/279/DC1). These experiments clearly show thatin which invasion was inhibited by up to 2.4-fold in the clone
1273 4-3 (p  0.02) and up to 1.7-fold in the clone 1273 4-7 both the activity level of the presumptive Wnt5a signaling path-
way and the activity level of the invasive phenotype are in-(p  0.08). In an endogenously high-Wnt5a-expressing cell line,
UACC 647 Frizzled-5 antibody inhibited the invasion of these creased by increasing the level of the Wnt5a ligand and are
decreased by desensitization of the Wnt5a receptor to the pres-cells by over 2-fold (p0.035). This inhibition was also observed
in scratch assays. First, using a scratch assay, cells were seeded ence of its ligand.
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Figure 6. Wnt5a staining of human melanoma
A: Distribution of Wnt5a positivity among tumor
types. Wnt5a negativity is represented by blue,
moderate positivity for Wnt5a is represented by
orange, and strong positivity for Wnt5a is repre-
sented by red. Where tumors stained mostly neg-
ative with a few foci of positivity, areas are
shaded gray. Most benign tumors (NEVI) stain
negative for Wnt5a, with two staining focally pos-
itive. Wnt5a staining is heterogeneously distrib-
uted among primary melanomas (PRIMARY MEL-
ANOMA), but most metastatic tumors stain
positive for Wnt5a (METASTASES), with one ex-
ception. Interestingly, none of the metastases
observed thus far stained focally positive for
Wnt5a. B–J: Wnt5a protein expression in human
tissue. Tissues were stained with the antibody to
Wnt5a, were secondary-stained with Cy-5 (red
staining), and were counterstained with DAPI
(blue staining). The distribution of the protein
among tissue and cell types was observed.
Wnt5a is not expressed in the majority of nevi (B),
except in two out of the eight samples, in which
there is focal positivity for Wnt5a (C), although
most of the sample and the epidermis stains neg-
ative ([C], arrow). In primary melanomas, the
staining was more heterogenous, where some
tumors stained only focally positive for Wnt5a (D)
and others stained strongly throughout the tumor
(E). In one primary melanoma, where cells were
in vertical growth phase, cells at the leading
edge of invasion into the extracellular matrix
were strongly positive for Wnt5a (F). Eight out of
nine metastases exhibited positive staining (G),
which was specific to the melanoma cells and
not to surrounding cell types such as lympho-
cytes ([H], arrow). Upon increased magnification
of cells exhibiting giant cell morphology, a phe-
notype that is highly associated with malig-
nancy, Wnt5a staining is strongly positive, as it
usually is in these cases (I). In this particular
biopsy, the time to metastasis was 17 months,
and the patient did not survive. Interestingly, in a
histopathologically similar tumor, there was very
focal Wnt5a positivity, with mostly negative stain-
ing through out the tumor (J). This is an unusual
observation for these types of tumors, as most
are strongly positive for Wnt5a; the patient did
not present with metastases for several years and
is still alive today.
High Wnt5a expression in tumors is prevalent in cells static portion of the tumor. What was seen in the previous
profiling study (Bittner et al., 2000) is consistent with this view.of particular histological types that are more
frequently observed in higher grades of tumor High Wnt5a expression was not observed in any of the tumor
biopsies examined in that paper. High Wnt5a expression wasIt has long been appreciated that the fraction of cells in a given
tumor that are actively moving to a site distant from the primary only observed in some clonal cell lines derived from melanomas.
To further test the expectation that high Wnt5a expressiontumor is small. An early study investigated the rate at which a
transplanted fibrosarcoma, a tumor known for shedding cells would be observed only in the limited fraction of cells in tumors
that were actively invasive, tissues of varying stages of melano-into the circulatory system, could place cells into the blood-
stream. It was observed that a tumor having a volume of 1.5–2 mas from 27 patients were analyzed for Wnt5a expression in a
blind comparison. Paraffin-embedded tumors were sectioned,ml released approximately 104 cells to the blood circulation per
day (Liotta et al., 1974). Given the premise that a mere 1% of and serial sections were mounted and subjected to either stan-
dard histochemical staining with hematoxylin and eosin (H&E)cells within a high-grade primary tumor exhibit a metastatic
phenotype, it is reasonable to assume that these cells would or to immunohistochemical staining using a biotinylated Wnt5a
antibody and a streptavidin-Cy5 secondary antibody with aconstitute such a low percentage of the total mass of the tumor
that any RNA expression pattern derived from this metastatic DAPI nuclear counterstain. H&E-stained sections were used to
choose regions of the tumor where the cells displayed featurescell population would most likely be diluted to undetectability
by the gene expression pattern of the more abundant, nonmeta- associated with more aggressive tumor behavior (high-grade
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Table 1. Distribution of Wnt5a positivity and relation to pathology, outcome, and survival data
Time to development
Pathology Wnt5a of metastasis Survival status
Nevus negative none living-no tumor
Nevus negative none living-no tumor
Nevus negative none living-no tumor
Nevus negative none living-no tumor
Nevus negative none living-no tumor
Nevus negative none living-no tumor
High-risk nevus focally positive none living-no tumor
High-risk nevus focally positive-strong lost to follow-up unknown
Primary melanoma negative none in 3 years living-no tumor
Primary melanoma positive 2 years unknown
Primary melanoma focally positive-strong 16 months deceased
Epidermis melanoma in situ strong local recurrence living-no tumor
Thin invasive melanoma strong 22 months living-with tumor
Primary melanoma focally positive 9 years living-with tumor
Primary melanoma, stem cell cytology negative unknown unknown
Primary melanoma positive local recurrence living-no tumor
Ewing’s sarcoma-like primary melanoma strong 10 months living-with tumor
Primary-vertical growth phase strong lost to follow-up unknown
Lymph node metastasis positive 7 years living-no tumor
Lymph node metastasis strong 24 months deceased
Dermal satellite metastasis negative 4 years living-with tumor
Lymph node metastasis strong 4.5 months deceased
Lymph node metastasis with phagocytosis strong-negative around phagocytosis 6 years living-with tumor
Satellite metastasis positive 31 months living-with tumor
Metastasis, with giant tumor cells strong 17 months deceased
Metastasis with giant cells strong 26 months deceased
Lymph node metastasis postive 10 months unknown
Wnt5a overexpression correlates strongly both to survival and time to the development of metastases. Time to the development of metastases is defined
as the time elapsed from when the patient was first diagnosed with a primary melanoma to when the first metastasis was excised, as determined by
pathology lab accession numbers.
cytology). When such areas could not be found, areas were showed regions of moderately positive staining, and five showed
regions of strongly positive staining. These results are summa-examined in which the cells displayed features associated with
less aggressive tumor behavior. These regions were then micro- rized graphically in Figure 6A. Examples of the cell morphology
and Wnt5a staining patterns observed are displayed in Figuresscopically located on the Wnt5a antibody-stained slide, guided
by the DAPI counterstain, and then imaged with a digital CCD 6B–6J, and the details of this staining are described in the figure
legend. The relationship of Wnt5a staining to tumor pathologycamera for Wnt5a and DAPI staining. Wnt5a staining was graded
in three levels, based on the intensity of the staining. Areas were and patient outcome is described in Table 1.
While these data strongly suggest that cell populations withcalled negative where no patterns of membrane-associated
staining having an intensity of greater than 300 (arbitrary units) strong Wnt5a expression become more pronounced in higher-
grade tumors, the examples given do not represent a singlecould be detected. Areas were graded as low to medium positive
where typical membrane-associated staining could be detected natural history of a given melanoma, but only snapshots of many
different histories. To provide a longitudinal view of disease inwith intensities of 500–1000. Areas with typical membrane-
associated staining and intensities of 1000–4000 were graded a single case, a series of samples from the course of the disease
in a single patient who presented with acralentigious melanomaas strongly positive.
The distribution of samples exhibiting areas of negative, were examined. The primary tumor was located on thumb distal
periungual skin. It was excised, but only to the limit of theweak, and strong Wnt5a staining in nevi, primary melanoma,
and metastatic melanoma is shown in Figure 6A. It is easier to superficial invasion, and was therefore reexcised to capture the
leading margins of invasion. Over the next 2 years, metastaticfind cells with malignant features as tumor grade increases, and
these cells frequently display strongly positive Wnt5a staining. melanoma to axillary lymph nodes was surgically removed. Cells
from the region of superficial invasion stained mostly negativeIn eight samples previously diagnosed as nevi, only two, both
congenital nevi, showed Wnt5a staining. In both cases, the for Wnt5a, except within the superficial invasive component,
where there was moderate positivity (Figure 7A). Cells from thestaining was confined to a small focus of cells showing multiple
nucleoli, a hallmark of abnormal nevus cells. The ten tumors next excision, at the leading edge of invasion, were strongly
positive for Wnt5a (Figure 7B,arrow). The tumor samples fromdiagnosed as primary melanoma showed a wider gamut of stain-
ing, two were negative, two showed a few microfoci of strongly the early metastases to the axillary lymph nodes were mixtures
of common morphological types of melanoma cells, epithelioidpositive staining, two displayed moderately positive staining,
and four had large zones of strongly positive staining. The eight and sarcomatoid. The epithelioid cells showed lower levels of
Wnt5a staining, while the sarcomatoid cells showed highly posi-samples of metastatic tumors showed an even greater fraction
of cases with strong staining. One sample was negative, three tive staining (Figure 7C). In keeping with the hypothesis that
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stabilization. Instead, Wnt5a activity has been shown to activate
PKC (Kuhl et al., 2000). PKC has long been known to be associ-
ated with cytoskeletal changes and increases the motility of
several types of cells, including melanocytes (Szalay et al.,
2001). Moreover, PKC inhibitors have been shown to inhibit the
ability of melanoma cells to invade through artificial basement
membrane in vitro (Dennis et al., 1998). The many excellent
studies implicating the PKC pathway as being central to invasion
in melanoma elicit the question of how this pathway is induced.
In this paper, we show that increasing or inhibiting Wnt5a ex-
pression produces a corresponding effect on PKC activation.
In addition, our experiments provide direct evidence that in-
creased Wnt5a expression is capable of increasing the in vitro
motility and invasion of melanoma cells (Figure 4C). Frizzled-5
is implicated as the receptor activated by Wnt5a in this process
by observations that disabling the receptor for Wnt5a leads to
a reduction of both PKC activity and in vitro motility and invasion
of melanoma cells (Figure 5). The detection of PKC isoform-
specific phosphorylation patterns associated with the increased
motility and invasion (Figure 4B) provides further definition of
the likely route of this signal’s transduction. Available data sug-
gest that there may be a complex regulatory connection be-
tween Wnt5a and PKC. Prior published work (Jonsson et al.,
Figure 7. Natural history of an acralentigous melanoma 1998) demonstrates that the increase or inhibition of PKC activ-
A–D: In this index case, not included in the above data, a patient presented ity results in increased or inhibited Wnt5a expression, while the
with an acralentigious melanoma of the thumb. The tumor was excised current observations show that the reverse is true as well. These
and was composed mostly of keratin and some melanoma cells (A). The
observations suggest the possibility that the activities of Wnt5aexcision only captured the superficial edge of invasion, and the tumor cells
and PKC drive a positive feedback loop, perhaps a Wnt5a auto-at this edge were slightly positive for Wnt5a (A). Because the margins were
not clear, the tumor was reexcised, and this time the leading edge of crine loop, and that increases in the activity of either may result
invasion was captured (B). The cells that were actively invading were in increased melanoma motility.
strongly positive for Wnt5a (B). Six months later, this patient presented with In addition to displaying the expected characteristics of ana metastasis to the axillary lymph node. This tumor was composed of both
inducer of metastatic behavior, Wnt5a is an attractive candidateepitheloid and sarcomatoid cells (C); however, the sarcomatoid cells were
much more positive for Wnt5a than the epitheloid cells ([C], arrow). This on the basis of its normal function. In embryonic development,
became increasingly significant when the next metastasis, which occurred as neural crest cells migrate to the skin, they express high levels
1 month later, was entirely sarcomatoid in its composition (D). of Wnt5a, which results in increased morphogenetic movement
in developing cells (Christiansen et al., 2000). When the cells
reach their site of differentiation and become melanocytes, the
expression of the Wnt5a gene drops to very low levels. Based
stronger Wnt5a expression connotes higher invasive compe- on our current data and that of others (Bittner et al., 2000; Iozzo
tence, the distant metastasis observed in this patient was com- et al., 1995), it appears that reexpression of detectable Wnt5a
pletely sarcomatoid in its morphology (Figure 7D). While these is induced by a molecular event occurring during the progres-
initial in vivo staining results provide only a sketch of Wnt5a’s sion of a melanocyte to malignancy, resulting in increased motile
localization in melanoma, the observations are consistent with and invasive competence in those cells. The means of control
what has been previously observed in molecular biological and of Wnt5a expression are not well elucidated, making it difficult
biochemical studies of Wnt5a to date. Taken as a whole, our to propose models of how increased Wnt5a expression might
data support the notion that the Wnt5a/PKC pathway could be achieved during progression. Factors known to alter Wnt5a
play an important role in evoking the invasive phenotype of expression include hepatocyte growth factor (Huguet et al.,
metastatic melanoma and that Wnt5a may be a potential marker 1995), as well as c-Ha-ras, perhaps as a result of transduction
of tumor progression. of signals from the extracellular matrix (Bui et al., 1997). Further
experimentation is required to support the notion that Wnt5a
Discussion mediates interactions with the extracellular matrix in melanoma
cells.
Previous studies of the gene expression profiles of melanoma As with most signal transduction cascades, activation may
indicated that WNT5A is an important marker that is highly be achieved by many paths. Another route to stimulation of PKC
correlated with enhanced motility and invasiveness (Bittner et that affects cell motility is the Rho C pathway, which appears to
al., 2000), suggesting that this gene might play a role in tumor be able to increase PKD (PKC) (Yuan et al., 2000), an isoform
metastasis. To further examine this possibility, we have exam- involved in cytoskeletal rearrangements and integrin activation
ined the effects of this gene’s expression in vitro and the distri- (Palmantier et al., 2001). This stimulus has also been shown to
bution of its expression in melanoma in vivo. increase the motility of melanoma cells (Clark et al., 2000). In
Unlike other Wnt family members (e.g., Wnt1 and Wnt8), addition, Wnt1 is able to regulate the expression of some Rho
family members (Tao et al., 2001). The convergence of both theWnt5a expression does not have a profound effect on -catenin
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onto 0.4 m nitrocellulose. The membranes were probed with antibodiesWnt5a and Rho C pathways to activate PKC provides a way
and were then visualized using the ECL system (Amersham).for cellular motility to be conditioned by a variety of extracellular
signals.
Real-time PCR analysis
Early studies of Wnt5a RNA expression in tumors indicated Real-time PCR analysis was performed using the Roche Light Cycler. Briefly,
that, on a gross level, many tumors showed increased Wnt5a cells were grown to about 85% confluency and were then harvested for
RNA using the Qiagen Rneasy Kit (Qiagen). RNA was analyzed for integrityexpression relative to their normal tissue of origin, and that
using formaldehyde agarose gel electrophoresis and was quantitated. Amelanomas showed increased Wnt5a expression relative to skin
total of 0.5 mg of RNA was then subjected to real-time RT-PCR using the(Iozzo et al., 1995). In this study, we show that the increased
SYBR Green 1 LightCycler RT PCR kit (Roche). The primers used for Wnt5aexpression of Wnt5a in melanoma tumors is localized, occurring were: left primer; 5-AGGGCTCCTACGAGAGTGCT-3, and right primer; 5-
in cells at the site of active invasion and in cells showing morpho- GACACCCCATGGCACTTG-3. For Frizzled-5, the primers used were: left
logical features associated with aggressive tumor behavior. This primer; 5-CCTACCACAAGCAGGTGTCC-3, and right primer; 5-GGACAG
GTTCTTCCTCGAAA-3.initial study sets the stage for further tumor progression studies
of Wnt5a expression in melanoma, and its correlation to out-
Immunohistochemistrycome will be examined via tumor microarrays.
For -catenin staining, cells were grown on glass slides and were allowed
In summary, our experiments demonstrate that Wnt5a, to reach 80% confluency. They were then fixed using methanol and were
through its activation of PKC, contributes to the acquisition of a washed in PBS. Nuclei were permeabilized by incubating the cells in 0.4%
highly motile and invasive phenotype consistent with aggressive NP40 in PBS (pH 7.4, calcium and magnesium free) for 10 min. Slides were
washed and then blocked with horse serum for 1 hr, followed by an overnightmelanoma behavior. Wnt5a potentially mediates its effects by
incubation at 4C in either -catenin primary antibody (Transduction Labora-its ability to activate protein kinase C. It is possible that pharma-
tories) or in Wnt5a (0.2 mg /ml) or by phalloidin staining for actin (Molecularcological inhibition of this pathway could be targeted to reduce
Probes). The cells were washed again with PBS for 30 min and were then
the motility of these cells. Our findings are of particular interest, probed with an FITC-conjugated secondary antibody for 1 hr (-catenin).
because unlike PKC, a molecule ubiquitous and active in all cell Cells were then washed, mounted in anti-fade, and examined under fluores-
types, Wnt5a signaling does not appear to be common in adult cence.
For Wnt5a staining of paraffin-embedded tissue, paraffin-embeddedorgans. As such, Wnt5a signaling might be a potential therapeu-
tumors were sectioned and deparaffinized using a xylene, xylene, 100%tic target for the inhibition of melanoma progression.
ETOH, 95% ETOH, 75% ETOH, H2O series, and antigens were retrieved by
steaming samples in DAKO target retrieval buffer (DAKO) for 20 min. SectionsExperimental procedures
were rinsed in PBS, were subjected to immunohistochemistry using a biotin-
ylated Wnt5a antibody and a streptavidin-Cy5 secondary antibody, and wereCell lines
analyzed by immunofluorescence using a 12-bit CCD camera.The human melanoma cell lines UACC 1273, UACC 647, M92-047, and
UACC 930 were cultured in RPMI-1640 media supplemented with 10% fetal
Invasion and motility assaysbovine serum (Hyclone), 100 U/ml penicillin G, and 100 U streptomycin.
Scratch assays were performed by plating cells in slide chambers coatedSW480 cells were a generous gift of Drs. Kenneth Kinzler and Bert Vogelstein
with fibronectin or collagen. After cells were allowed to attach and reach(Johns Hopkins Medical Institution, Baltimore, MD) and were maintained in
confluency, a scratch was made through the fibronectin or collagen. Photo-McCoy’s 5A medium with 5% FBS. All cell cultures were incubated at 37C
graphs of cells invading the scratch were taken at the indicated time points.in 5% CO2/95% air, and the medium was replaced every second day.
Invasion assays were performed using Matri-gel-coated Fluoroblok invasion
chambers. The day before the assay, 8 mM fluoroblok filters (12 mM inTransfections
diameter) were coated with 150 l 80 mg/ml reconstituted basement mem-Cells were seeded in slide flasks and were allowed to reach 80% confluency.
brane (Matrigel) and then placed in a sterile hood to dry overnight. A total
The cells were transfected with the Gateway destination plasmid PCDNA3-
of 16 hr prior to the assay, all cells to be assayed were serum starved. Prior
Wnt5a or the empty vector controls, using Lipofectamine Plus (GIBCO-
to the assay, cells were treated with 5 mM Calcein-AM for 1 hr at 37C.
BRL). After 6 hr of transfection, the medium was replaced with fresh serum-
After this time, cell viability was examined using trypan blue exclusion, and
containing medium. For stable transfectants, medium was replaced after 48
then 50,000 cells were seeded onto the top of Fluoroblok filters. The total
hr with G418-containing medium, and transfectants were selected. volume on the top of the filter was adjusted to 800 ml of serum-free medium.
A total of 800 ml of the identical medium, with the addition of 10% fetal calf
Cell adhesion assays serum, was placed in the well beneath the filter to act as a chemoattractant.
Cells were trypsinized, counted, and then seeded into 96-well plates at a The cells were then placed in the 37C-humidified incubator for 15 min, after
density of 50,000 cells per well for 5, 15, and 30 min. Each time point was which an initial reading was taken. All readings were performed on a Cytofluor
stopped by aspirating floating cells, rinsing the wells with PBS, and then 4000 with an excitation/emission of 480/530 and a gain of 50, using bottom
fixing and staining the cells with 0.5% crystal violet in 50% methanol. Cell read fluorescence only. Readings were taken every hour for 4–6 hr. All cell
density was determined spectrophotometrically by dissolving the stain in lines were assayed in triplicate in each experiment, and each experiment was
the fixed cells with acetic acid and by measuring absorbance at OD 560 repeated three times. ANOVA analysis was used to determine the statistical
nM. Each time point was assayed in triplicate, and each experiment was significance of the results, and standard deviations and p values are shown.
repeated three times.
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